Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Feb;21(2):69.
doi: 10.1038/s41569-023-00970-3.

SELECT shows cardiovascular risk reduction with weight-loss drug semaglutide in people without diabetes

Irene Fernández-Ruiz  1
Affiliations
Comment

SELECT shows cardiovascular risk reduction with weight-loss drug semaglutide in people without diabetes

Irene Fernández-Ruiz. Nat Rev Cardiol. 2024 Feb.
No abstract available

PubMed Disclaimer

Comment on

  • Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
    Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.

References

Original article
    1. Lincoff, A. M. et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2307563 (2023) - DOI - PubMed
Related article
    1. Ussher, J. R. & Drucker, D. J. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nat. Rev. Cardiol. 20, 463–474 (2023) - DOI - PubMed

MeSH terms

LinkOut - more resources